Skip to main content

FDA issues warnings to 2 companies marketing CBD as opioid alternatives

salazar

The Food and Drug Administration has sent warning letters to two companies it said were marketing products in a way that violates the Food, Drug, and Cosmetic Act. The agency said the action was part of its work to go after companies illegally marketing CBD products with claims that they can treat medical conditions, among them opioid addiction. 

"The opioid crisis continues to be a serious problem in the United States, and we will continue to crack down on companies that attempt to benefit from selling products with unfounded treatment claims," said FDA principal deputy commissioner Dr. Amy Abernethy. "CBD has not been shown to treat opioid addiction. Opioid addiction is a real problem in our country, and those who are addicted need to seek out proper treatment from a health care provider. There are many unanswered questions about the science, safety, effectiveness and quality of unapproved products containing CBD, and we will continue to work to protect the health and safety of American consumers from products that are being marketed in violation of the law."

Biota Biosciences, based in Washington state, was issued a warning letter for marketing and distributing injectable CBD products, as well as an injectable curcumin product, as an alternative to opioids. The company, which also makes private-label CBD and wholesale CBD extracts, also sells beverages, bulk CBD extracts and water-soluble CBD. 

The agency also issued a warning letter to Homero, doing business as Natures CBD Oil Distribution. The New Hampshire-based company was cited for marketing and distributing CBD products as a treatment for opioid addiction, among other diseases. The company is a retailer for Green Roads CBD products and an own-label distributor for CBD products. 

The companies have 15 working days to provide a response to the FDA stating how they plan to correct the violations. The FDA said failure to correct the violations promptly could lead to legal action, including product seizure and injunction. 

Most Popular Content

Kroger Expands In-Store Media Solutions

Digital screens built into integrated fixtures, such as endcaps, will begin appearing across select Kroger stores. Browse gallery of images sent to P2PI.
Kroger Barrows Connected Store Thumbnail

Leveling Up Loyalty: How CPGs Are Using Gamification to Win Shoppers In-Store and Beyond

Brands and retailers are embracing game mechanics in physical retail to create immersive experiences and generate consumer insights.
in-store gamification

Walgreens Shifts In-Store Media Strategy

Vestcom expands its role with Walgreens as the drug chain evolves its at-shelf retail media approach.
walgreens

Path to Purchase Trends 2025, Part 2: Social Media, AI & More

Our annual survey shows how brand investments in social media and retail media continue to rise, while the commitment to AI is surging.
p2pi trends report

Retail Media Levers: Where Brands Can Focus to Prepare for Their Next Leap

Industry insiders weigh in on a variety of topics to help brands prepare for what's next in retail media, including loyalty, talent and self-service capabilities.
retail media
X
This ad will auto-close in 10 seconds